Daxor

BVA-100 Key Features

Blood Volume Analyzer

• 98% accurate measure of total blood, plasma and red cell volume
• Simple blood test with results ready in less than 6O minutes
• Quantifies volume deviation vs patient-specific ideals
• Unique measure of capillary permeability

Discover More

Rapid. Accurate. Individualized. Actionable. Reimbursed.

Rapid.
Accurate.
Individualized.
Actionable.
Reimbursed.

Token Sale

Heart Failure

56% Reduction in 30-Day Readmissions
82% Reduction in 30-Day Mortality
86% Reduction in 365-Day Mortality
62% Identified as Anemic

Discover More

Critical Care

66% Reduction in Mortality
20% Reduction in Length of Stay
36 Hour Earlier Treatment Decisions
44% Change in Treatment Strategy

Discover More

Published research from leading
institutions has established the value of the BVA-100

Cleveland Clinic • Columbia • Mayo Clinic
NYU • Yale • Vanderbilt • Virginia Commonwealth University

Published research from leading
institutions has established the value of the BVA-100

• NYU

• Virginia Commonwealth University

View Our Story

BVA-100 Impact Points

Token Sale

Providers

Enables better clinical decisions to improve quality of care

Payers

Reduces mortality and readmissions and lowers the cost of care

Patients

Provides your doctor with the information needed to optimize treatment

Discover More

Token Sale

Providers

Enables better clinical decisions to improve quality of care

Discover More

Payers

Reduces mortality and readmissions and lowers the cost of care

Discover More

Patients

Provides your doctor with the information needed to optimize treatment

Discover More

Token Sale

News & Events

13
NOV 2018

New Data Demonstrates Clinical Utility of Daxor Corporation’s Blood Volume Analyzer (BVA-100) in Evaluation of Hypertension

08
NOV 2018

New Data Demonstrating the Clinical Utility of Daxor’s BVA-100 in Hypertension Management to be Presented at the American Heart Association’s Scientific Sessions 2018

07
NOV 2018

New Data Demonstrating the Clinical Utility of Daxor Corporation Selected for U.S. Army Contract to Develop a Blood Volume Analyzer for Improvement of Combat Casualty Care

Token Sale

Daxor Corporation is an innovative medical instrumentation and biotechnology company focused on blood volume analysis.

Token Sale

The BVA-100 is an FDA-cleared diagnostic instrument to measure a patient’s blood volume, calculate an ideal blood volume that the patient should have, and indicate hypovolemia or hypervolemia with statistics showing the quality of results.

Contact Us

865-425-0555
info@daxor.com

56% Reduction in 30-Day Readmissions 82% Reduction in 30-Day Mortality 86% Reduction in 365-Day Mortality 62% Identified as Anemic

66% Reduction in Mortality 20% Reduction in Length of Stay 36 Hour Earlier Treatment Decisions 44% Change in Treatment Strategy

56% Reduction in 30-Day Readmissions
82% Reduction in 30-Day Mortality
86% Reduction in 365-Day Mortality
62% Identified as Anemic

66% Reduction in Mortality
20% Reduction in Length of Stay
36 Hour Earlier Treatment Decisions
44% Change in Treatment Strategy